Global Personalized Medicine Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Personalized medicine, also termed Theranostics or precision medicine, is a medical procedure that separates patients into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.[1] The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept[1][2] though some authors and organisations use these expressions separately to indicate particular nuances. The Personalized Medicine market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Personalized Medicine market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Personalized Medicine Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Personalized Medicine market are: QIAGEN Genelex Corporation Celera Diagnostics LLC Decode Genetics, Inc. GE Healthcare Exagen Diagnostics, Inc. Biogen, Inc Abbott Laboratories Asuragen, Inc. Danaher Corporation (Cepheid, Inc.) Precision Biologics, Inc Exact Science Corporation Dako A/S Illumina, Inc. Most important types of Personalized Medicine products covered in this report are: PM Diagnostics PM Therapeutics Personalized Medical Care Personalized Nutrition & Wellness Most widely used downstream fields of Personalized Medicine market covered in this report are: Diagnostic Companies Pharmaceutical Companies Healthcare Companies Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.